Introduction

Xiang Qide is a member of the Chinese Society of Clinical Oncology (CSCO) under the China Anti-Cancer Association. With over 30 years of clinical experience in medical oncology, he has long been dedicated to the systemic treatment and precision management of malignant tumors, possessing profound medical theoretical knowledge and extensive practical expertise in frontline diagnosis and treatment.

He specializes in systemic therapies (chemotherapy, targeted therapy, immunotherapy) for cancers including lung cancer, breast cancer, colorectal cancer, liver cancer, gastric cancer, esophageal cancer, lymphoma, and head and neck tumors. He has particularly profound expertise in bronchoscopic diagnosis and interventional therapy, with mastery of minimally invasive techniques such as bronchoscopic tumor resection, tumor thermal ablation, and bronchial stent placement. His clinical efficacy is outstanding and has earned high trust from patients.

Education Background

Nanhua University, Clinical Medicine

Medical Experience

Member of the Chinese Society of Clinical Oncology (CSCO)

Completed multiple advanced training programs at renowned domestic specialized cancer hospitals

Academic Achievements

Published over 10 academic papers in national and provincial-level professional journals in the field of oncology.

*Surgery, in addition to the appropriate chemotherapy and radiotherapy, are effective in treating early cancer, but certain patients in late stage of cancer may not be tolerate surgery well as they can be relatively weak. A combination of carefully planned minimally invasive therapy, chemotherapy or radiotherapy can effectively reduce the side effects and discomfort of treatment and may help patient get better efficacy.